ClinConnect ClinConnect Logo
Search / Trial NCT05632107

Comparison of an Acceleromyography- and Electromyography-based Neuromuscular Monitor With TOF-Watch ® Monitor

Launched by HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY · Nov 20, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Neuromuscular Blocking Agents; Residual Neuromuscular Blockade; Neuromuscular Monitoring; Acceleromyography; Electromyography

ClinConnect Summary

This clinical trial is studying a new device that measures muscle relaxation during surgery, specifically looking at how well it works compared to a standard device called the TOF Watch®-SX. Muscle relaxation is important for certain surgeries, and the trial aims to see if this new device, which combines two types of monitoring technologies, can provide accurate information about muscle relaxation without the complicated setup that other devices often require.

To be eligible for this trial, participants must be under 18 years old, be in good health (with a physical status of I to III), and be scheduled for elective surgery that requires muscle relaxation. Participants will need to voluntarily agree to take part and sign a consent form. Those with certain medical conditions, such as neuromuscular disorders or a history of allergic reactions to muscle relaxants, will not be included. If you choose to participate, you can expect to help researchers understand whether this new device can improve the safety and effectiveness of monitoring muscle relaxation during surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age less than 18 yr
  • American Society of Anesthesiologists Physical Status I to III
  • Elective surgery requiring muscle relaxation
  • Patients participated voluntarily and signed informed consent
  • Exclusion Criteria:
  • Patients with known neuromuscular disorder
  • Stroke
  • Patients with a history of allergic reaction toneuromuscular blocking agents
  • Use of medications that might interfere with neuromuscular transmission
  • Any previous injury to the examined arm that might influence nerve conduction parameters
  • Pacemaker

About Huazhong University Of Science And Technology

Huazhong University of Science and Technology (HUST) is a prestigious research university located in Wuhan, China, renowned for its commitment to advancing scientific knowledge and innovation in various fields, including medicine and healthcare. With a strong emphasis on interdisciplinary collaboration, HUST engages in cutting-edge clinical research aimed at improving patient outcomes and driving advancements in medical science. The university's clinical trial initiatives are supported by state-of-the-art facilities and a team of experienced researchers, making it a key player in the development of novel therapies and treatment strategies in the healthcare sector.

Locations

Wuhan, Hubei, China

Wuhan, Hubei, China

Patients applied

0 patients applied

Trial Officials

Hua Zheng, Dr.

Study Director

Department of Anesthesiology, Tongji Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials